Medicine Related Topics 
pharmaphorum
OCTOBER 12, 2022
Genomic medicine is a rapidly growing space in which researchers use the information in a person’s genes to identify and administer medical treatment.”. The evolving field of genomic medicine. There are two components to genomic medicine, known as the payload and the vector.
pharmaphorum
JANUARY 17, 2023
Late last year, pharmaphorum spoke with AstraZeneca’s Ben Challis, VP and head of translational science and experimental medicine, cardiovascular, renal, and metabolism (CVRM), together with Magnus Jörnten-Karlsson, executive director of Unify.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
FEBRUARY 23, 2023
After splashing $1B, Roche returns lagging cancer drug Gavreto to Blueprint Medicines aliu Thu, 02/23/2023 - 11:14
pharmaphorum
JANUARY 20, 2023
Leela Barham argues that the latest operational guidance for the NHS in England continues to illustrate a disconnect between the messages in big-ticket policy documents from the central government and the messages from the NHS in England on medicines.
.png)
MedCity News
JULY 27, 2022
A panel discussion on the future of digital medicine highlighted some of the collaborations taking place between pharma companies and digital health, as well as some of the challenges facing the push towards mainstream implementation.
pharmaphorum
JANUARY 27, 2023
So, here are three “best guesses” for what 2023 will hold for the off-patent medicines segment — which accounts for roughly 70% of medicines prescribed worldwide (including the vast majority of system-critical antibiotics and ICU therapies), but only about 20% of the total cost.
World of DTC Marketing
DECEMBER 4, 2020
Digital medicine has been thrust into the spotlight because of the pandemic and the media hype is in overdrive. A study of some 16m American ones just reported in jama Internal Medicine , a journal, found that their use of telemedicine surged 30-fold between January and June.
pharmaphorum
OCTOBER 28, 2022
In June, NHSE and NICE published details on the Innovative Medicines Fund, which will help improve patient access to cutting-edge medicines, with a particular focus on rare diseases, and ensure global pharmaceutical and biotech organisations continue to prioritise the UK as a launch destination.
MedCity News
JANUARY 8, 2023
Zimmer Biomet pursued the deal to grow its sports medicine portfolio and gain entry into the high-growth rotator cuff augmentation submarket, an executive said. Daily Devices & Diagnostics Health Tech SYN Top Story acquistion Embody orthopedics sports medicine Zimmer Biomet
pharmaphorum
NOVEMBER 16, 2022
The 2022 edition of the Access to Medicine Index (ATMI) – which places the top 20 pharma companies for their efforts to improve delivery of medicines to lower income countries – sees GSK retain the number one position, newly joined by Johnson & Johnson in second and AstraZeneca in third.
pharmaphorum
JANUARY 24, 2023
Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition. The post Call to arms as UK falls back in medicines manufacturing appeared first on.
pharmaphorum
OCTOBER 12, 2022
The Eureka Institute, a Syracuse, Italy-based non-profit, is focused on addressing this disparity by providing education, research, and advocacy around the field of translational medicine. Translational medicine and digital health.
MedCity News
DECEMBER 8, 2022
The Food as Medicine movement has received a lot of interest from payers and health systems recently. Consumer / Employer Daily SYN Top Story Alight food as medicine food insecurity nutrition
European Pharmaceutical Review
FEBRUARY 13, 2023
Tokyo researchers have developed a new analytical platform based on liquid chromatography, mass spectrometry and software analysis that quantifies the structure of messenger RNA (mRNA)-based medicines.
European Pharmaceutical Review
MARCH 14, 2023
Parallel import of medicinal products is one of the basic and admissible forms of international trade in the European Union (EU) market, based on the principle of free movement of goods established by the Treaty on the Functioning of the European Union.
Fierce Pharma
NOVEMBER 14, 2022
AstraZeneca and Sanofi win big as Europe's human medicines committee endorses approvals, label expansions. fkansteiner. Mon, 11/14/2022 - 08:59
European Pharmaceutical Review
FEBRUARY 21, 2023
The UK medicinal cannabis sector has witnessed important regulatory advances in recent years. Advising companies, he emphasised that those “manufacturing cannabis-based medicines should not underestimate the scale of the challenge.”
European Pharmaceutical Review
FEBRUARY 2, 2023
While manufacturers in Europe have contingency plans in place to avoid major disruptions of critical medicines, COVID-19 caused global supplies to dwindle due to the direct impact of pandemic lockdown measures in China and India.
Fierce Pharma
OCTOBER 10, 2022
Bayer, Hua Medicine snag first-in-class nod in China for Roche castoff diabetes drug, but commercial value uncertain. Mon, 10/10/2022 - 10:12
PharmaTech
JUNE 16, 2022
The new draft guidance describes a standards recognition program for regenerative medicine therapies.
pharmaphorum
JULY 5, 2022
Sanofi has said it will make 30 of its most commonly prescribed medicines available at non-profit prices to 40 lower-income countries, as part of a global health initiative launched by the company last year.
pharmaphorum
NOVEMBER 16, 2022
The North Ireland Protocol has been a source of tension between the UK and EU since it came into force at the start of 2021 – and according to one pharma company the end of the so-called ‘grace period’ could result in major issues with medicines supply.
PharmaTimes
JANUARY 18, 2023
Therapy is the first oral MET inhibitor treatment option for certain advanced NSCLC adult patients
MedCity News
SEPTEMBER 27, 2022
Prime Medicine likens its gene-editing technology to a word processor that searches for the correct place in the genome to make an edit, replacing or repairing a wide variety of target DNA.
pharmaphorum
OCTOBER 19, 2022
The post Battling breast cancer with precision medicine appeared first on. Partner content Patients Press releases breast cancer Oncology patient centricity patient journey precision medicineImage: Laura Holmes Haddad.
Pharmatutor
JANUARY 10, 2023
Lack of medicines in Greece and the solution of Generics. admin. Tue, 01/10/2023 - 15:46. Georgios-Marios Bolmpasis. MPharm Student University of Athens. Vice President of Pharmacy Students Association(Athens
Pharmaceutical Technology
JANUARY 16, 2023
CARsgen Therapeutics has announced a col labor ation with Huadong Medicine to commercialise zevorcabtagene autoleucel (zevor-cel), CT053, in mainland China. Under the collaboration, Huadong Medicine will have the exclusive right to commercialise CARsgen’s CT053 in mainland China.
PharmExec
AUGUST 10, 2022
Failed efforts do not overshadow field’s progress, resolve.
PharmExec
FEBRUARY 27, 2023
Blueprint Medicines Corporation will regain global commercialization and development rights to Gavreto (pralsetinib).
European Pharmaceutical Review
DECEMBER 22, 2022
Advances in mRNA technologies and cellular delivery systems coupled with their cost effectiveness, manufacturing simplicity and ability to target previously-undruggable pathways has limitless potential that could revolutionise medicine.
Pharma Leaders
MARCH 15, 2023
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has withdrawn all pholcodine-containing cough and cold medicines in the UK market as a precautionary measure following a review that the benefits do not outweigh the risk — though rare — of anaphylaxis from the opioid products.
Pharmaceutical Technology
DECEMBER 23, 2022
Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. The post Lilly and ProQR to expand genetic medicine development agreement appeared first on Pharmaceutical Technology.
MedCity News
AUGUST 30, 2022
Health data company CuriMeta launched on Tuesday and announced the close of a $6 million seed funding round led by its two institutional partners, BJC HealthCare and the Washington University School of Medicine.
PharmaTimes
OCTOBER 10, 2022
Medicines repurposing offers new avenues for treating a range of common and rare diseases
Pharmaceutical Commerce
MARCH 2, 2023
Following numerous successful trial runs, vaccine production is expected to reach 700 million.
pharmaphorum
JULY 5, 2022
Using drones will cut the transit time for the medicines from four hours to 30 minutes, and will also require less fuel – an increasingly important consideration as prices rocket at petrol pumps. The post NHS England trials first medicine deliveries by drone appeared first on.
PharmaTech
JULY 25, 2022
The agency’s human medicines committee recommended drugs to treat breast cancer, lupus nephritis, type 2 diabetes and more.
European Pharmaceutical Review
NOVEMBER 10, 2022
A new wave of medicines has emerged in recent years to supplement the well-established small and large molecule platforms that have historically dominated the market. Complex medicines offer diverse therapeutic modalities, including RNA therapeutics and antibody-drug conjugates (ADCs).
pharmaphorum
JANUARY 26, 2023
In June 2022, NHS England (NHSE) and the National Institute for Health and Care Excellence (NICE) launched the Innovative Medicines Fund (IMF). It builds on the Cancer Drugs Fund (CDF), an early access mechanism for many cancer medicines in England.
Pharma Leaders
MARCH 10, 2023
The financing round, which brings the total funds raised by the firm to $143.5m, was led by EQT Life Sciences, investing from Droia Ventures, Sanofi Ventures and the The post QurAlis raises funds to develop neurodegenerative disease medicines appeared first on Pharmaceutical Business review.
Expert insights. Personalized for you.
105 
Let's personalize your content